Charles W. Newton

Charles W. Newton has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Lyell Immunopharma, Inc., 2seventy bio, Inc. and Keros Therapeutics, Inc. The record holds 12 filings, for trades running from 9 February 2024 to 18 August 2026.

On the open market, the record shows 1 purchase worth €103k and 2 sales worth €6,085. The net balance comes to €96k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.

The newest entry dates from 20 August 2026: an open-market sale of €4,898, in Keros Therapeutics, Inc. The clock since the last published purchase (18 March 2025) now reads 579 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.